All results / Stories / Amy Stulick


ImmunoCellular Shareholders Approve Reverse Stock Split

Shareholders of ImmunoCellular Therapeutics have voted to implement a reverse stock split at a ratio not less than 1-for-3 and not greater than 1-for-10.

Endonovo's 1-for-1,000 Reverse Stock Split

Endonovo Therapeutics will execute a 1-for-1,000 reverse stock split of the company’s common shares.

Dignity Health, Cigna End Insurance Contract

After months of negotiations, health insurance company Cigna announced its contract with Dignity Health ended Jan. 1.

Amgen Beats Expectations Despite Lower Revenue

Amgen Inc. announced fourth-quarter results that beat Wall Street expectations.

Amgen Oncology Drug Struggles in Phase 1 Study

Nearly half of patients involved in a study for Amgen Inc.’s BiTE drug, an experimental cancer treatment, experienced adverse effects, according to data released Wednesday from its phase 1 study for myeloma.

Jant Pharmacal Wins Contract to Supply Lab Test Kits

Jant Pharmacal Corp. has won a contract with health care performance improvement company Vizient Inc., starting Feb. 1.

MannKind Receives $12.5 Million Milestone Payment

MannKind Corp. announced the first of several development milestones under a licensing and collaboration agreement with United Therapeutics as of April 1.

Kimball Steps Down as Cal Lutheran President

Monday marks Chris Kimball’s last day as president of California Lutheran University, with his successor, Lori Varlotta, taking the position on Sept. 1.

Tease photo

West Hills Hospital Closes Obstetrics Unit After 'Significant Decline' in Births

West Hills Hospital will close its obstetrics program effective Nov. 1, the organization announced earlier this month.

Biotech Company Purchases ImmunoCellular for $1 Million

ImmunoCellular Therapeutics Ltd. has announced a purchase agreement with a privately held biotech company, according to a statement from the Calabasas company on Tuesday.

Los Robles Hospital Buys Surgery Robot

Los Robles Hospital and Medical Center has spent $1 million to purchase a Stryker Mako Robotic-Arm for its Thousand Oaks Surgical Hospital.

Tease photo

Arcutis Adds Legal Expertise to Board

Westlake Village-based Arcutis Biotherapeutics on Monday appointed Halley Gilbert to its board of directors. effective May 1.

Arcutis Starts Eczema Clinical Trials

At a time when many other biotech companies have curtailed clinical trials, Arcutis Therapeutics has enrolled its first patient in a Phase 1 study of hand eczema topical drug ARQ-252.

Berke Miller Law Group Changing its Name

Calabasas law firm Berke Miller Law Group on Monday announced it will change its name to Miller Haga Law Group on Jan. 1.

Tease photo

Amgen’s Breakaway Challenge Coincides with Cycling Tour

Ahead of its May cycling event, Amgen Inc. has launched the Breakaway Challenge initiative, a national social fitness program aimed at motivating people to be healthier in the face of heart disease and cancer.

Amgen Discloses ‘Mini-Tender’ Offer

Amgen Inc. on Wednesday announced it had been notified of an unsolicited “mini-tender” offer by Canadian investment company TRC Capital Corp. to purchase 500,000 of its shares.

Lewitt Hackman Expands with GSA Addition

Lewitt Hackman will be adding four attorneys to its roster from fellow Encino law firm, Goldfarb Sturman & Averbach, on Sept. 1, following GSA's closing at the end of this month.

City Charges Non-Mask Wearers Who Fought Security Guards

Following a physical altercation over wearing masks at a Van Nuys Target store, two brothers have been charged with battery and trespass.

Arcutis Hires Chief Medical Officer

Arcutis Biotherapeutics on Monday announced the appointment of Dr. Patrick Burnett as its chief medical officer effective Aug. 1.

Amgen Foundation Gives $2 Million to Local Nonprofits

Amgen Foundation on Tuesday announced a $2 million contribution to more than a dozen organizations in Los Angeles and Ventura counties to help vulnerable populations impacted by COVID-19.